An experimental drug, empagliflozin, developed for treating Type 2 diabetes has been found to lower blood pressure in diabetic and hypertensive patients, a new study presented at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago reveals. This improvement in blood pressure reportedly was accompanied by a reduction in blood glucose (sugar) levels after 12 weeks of treatment with the drug, which is under ...
Read More
You have just read an article categorized health
titled Experimental Drug Found to Reduce High Blood Pressure in Diabetics and Hypertensive Patients.
Written by:
editor -
Thursday, June 26, 2014
There are currently no comments for "Experimental Drug Found to Reduce High Blood Pressure in Diabetics and Hypertensive Patients"
Post a Comment